A rabbit model is described j(H the evaluation of epiduralf,v administered local anaesthetic agents. The technique involves a single injection via the readily identified lumbosacral space in conscious rabbits, with the epidural space being identified by a modified loss-of-resistance technique. The endpoints used to assess pharmacodynamic responses of the rabbit model were (/) sensory loss, (2) loss qf weight-bearing ability, and (3) /faccid paresis. The model was further characterised by investigation of endpoinr responses to changes in injection volume (0.1-0.25 mIlkg) and concentration of administered lignocaine solutions (0.5 to 2%). From these studies, a volume of 0.2 mIlkg was chosen as a standard dose and a subsequent comparison between different agents undertaken. The rank orderfor the onset of action, duration of effect and the observed phannacokinetic pf'(~/ifes after epidural administration (~f 2% lignocaine, 2% lignocaine with adrenaline (/:200,000) or 0.5% bupivacaine solutions are broadly consistent with human cfinical data. These data indicate that the rabbit is a simple (albeit limited) model for the screening evaluation of epiduralfy administered local anaesthetic agents.
The rational and ethical assessment and evaluation of local anaesthetic or other agents for use in epidural analgesia requires careful pre-clinical investigation. I An intact animal model is necessary as the anatomical space is an important determinant of the pharmacological response. Several models have been described employing surgically implanted catheters in the dog, , cat,] pig,4 and rat. '.h However, these models are limited by potential surgical complications and catheter-related problems (e.g. dislodgement, blockage, inflammatory reaction and the possibility of infection). A direct epidural injection technique would circumvent these problems, although it may increase the risk of nerve and spinal cord damage with repeat injections. Despite the fact that direct epidural techniques are commonly practised in veterinary medicine, the procedures which have been described are inadequately characterised for application in experimental research. -'ll The purpose of the present study was to investigate the rabbit as a simple model for the assessment of epidural agents using a single-injection technique, thereby avoiding surgery, catheter implantation and chronic aftercare. Related studies in rabbits include both chronic implantation of a subarachnoid cannula I1 and single epidural injections of various formulations for subsequent histopathological assessment." The present investigation complements the histopathology study of Cicala and co-workers by assessing the clinical effect, duration of action and intensity of blockade after single direct epidural injection of local anaesthetics. Pharmacodynamic responses were assessed using three simple end points: (I) sensory loss, (2) loss of weight-bearing ability, and (3) flaccid paresis. The utility of the rabbit model was assessed by examining the ability of the system to relate changes in the administered volume and concentration of drug to these end points, and to differentiate between different anaesthetic agents in terms of their duration of action and pattern of differential blockade.
MATERIALS AND METHODS
Chemicals: Sterile solutions of 2070 w/v lignocaine HCI, 2070 w/v lignocaine HCI with 1:200,000 adrenaline, and 0.5070 w/v bupivacaine HCI were obtained from Astra Pharmaceuticals (Sydney, Australia). Tertbutylmethylether was obtained from Fluka (Switzerland) and all other reagents and chemicals were HPLC grade quality. Water was obtained from a Milli-Q (Waters, MA) water purification system.
Animals:
Experiments described in the current study were approved and performed in accordance with the 11l"('~fhn/(/ and Infemil'(, ('ure, f(J/. 1/, "0,3, June, /993 guidelines of the Institutional Animal Experimentation Ethics Committee. Adult rabbits (New Zealand White cross-strain, CSL Laboratories, Australia) of 3-4 kg were used. They were individually housed in standard cages with free access to food and water and a standard 12-hour light-dark cycle was maintained.
Epidural Technique: A modified "loss-of-resistance" technique derived from veterinary practice, and similar to that employed in caudal epidural injection in humans, was used. 8lO An assistant carefully restrained the rabbit on a table in a position of sternal recumbency by placing its head and forequarters under one arm while holding the stifle region of the hind legs in each hand. Sedation of the rabbit was not necessary. The readily palpable cranial dorso-iliac spines, lying on either side of the prominent spinous process of the seventh lumbar vertebra (L 7), served as landmarks. The thumb and middle finger of the left hand were placed on the two crests and the left index finger used to palpate the midline, L 7 spine and the depression over the lumbosacral fossa ( Figure 1 ). The unclipped hair was parted over the midline and the skin prepared with alcohol solution. With the index finger in position on the L 7 spine to serve as a guide, a short bevel 1.5 cm 20 gauge spinal needle was introduced at right angles to the skin in the midline with the bevel aligned longitudinally. If difficulty was encountered, slight movement in a cranial or caudal direction helped to locate the intervertebral space. After passage through the skin, only minor resistance was felt until the ligamentum flavum was reached. When passing through the ligamentum a definite "pop" was felt and resistance to advancement of the needle was lost. When correctly placed, the needle was at a depth of approximately 0.75 to 1.0 cm and was firmly held by the ligament. The stylet was then withdrawn and the hub inspected for the presence of blood or CSF. If present, or if the needle could not be positioned to allow resistance-free injection, the procedure was abandoned (approximately 10070 of cases). Otherwise, the needle was rotated through 90 0 to direct the bevel caudally, a 1.0 ml syringe was attached and 0.1 ml of air injected. Accurate placement was indicated by the absence of resistance to injection and lack of subcutaneous crepitus. A syringe containing the desired dose of the local anaesthetic agent was attached and the solution injected over a 5-10 second period. Movement during injection which could result in displacement of the injection occurred in a further 5% of cases, which were then abandoned.
Confirmation of epidural injection was performed using separate dissection and radiological methods. Methylene blue 0.5% was added to 2% w/v lignocaine solution and epidurally administered to two rabbits at Anaesthesia and intensive Care, Vol. 21, No. 3, June, 1993 a 0.2 mllkg dose. After a successful block was obtained, the animals were immediately sacrificed and the spinal column dissected to confirm the presence of dye confined to the epidural space. Similarly, radiological dye (lopamidol, 612 mg/ml) was added to the injected solution and the rabbit was X-rayed immediately after a successful block was obtained. The epidural location of the radiological dye was confirmed by a specialist radiologist (unpublished data).
A minimum of three blocks were performed for each different dose volume, administered concentration or particular agent. Placebo controls, performed using normal saline 0.2 mllkg, produced no effect in any of the measured endpoints. Pharmacodynamic Endpoint Assessment: The latency of onset and duration of three simple endpoints were used to assess the degree of blockade. Sensation was assessed by using a tail clamp where a rubbercovered six-inch clamp was closed over the base of the tail and rotated in its long axis. 13 Any sign of discomfort was noted and the stimuli ceased. Testing was performed at regular one-minute intervals until onset was identified, and at five-minute intervals thereafter. Loss of weight-bearing was noted when the animal could no longer spontaneously support its hindquarters, and recovery was readily discernible when the animal was again steady on its hind limbs. In these studies, flaccid paresis was defined as no discernible tone in either hind limb and was assessed at minute intervals until onset was detected and at five-minute intervals thereafter. Recovery was readily apparent when the animal demonstrated recovery of any muscle tone. There were no procedural or adverse drug-related effects in any of the rabbits and motor and sensory function always returned to normal.
Pharmacokinetic Studies: Venous blood samples (0.6 m!) were obtained from the marginal ear vein of rabbits prior to epidural administration and at 5, 10, 15, 20, 30,45, 60 and 90 minutes after administration of lignocaine (n=4); and at 5, 10, 15, 25, 40, 60, 90 and 120 minutes after administration of bupivacaine (n =4). Standard pharmacokinetic parameters were determined, which included the area under the plasma concentration-time profile (AUC) calculated using the trapezoidal rule, the maximum plasma concentration (C max ) and the time to reach the maximum plasma concentration (T max).
Analytical Procedures: The HPLC system consisted of a Waters 510 pump (Milford, MA), a UV detector operated at 220 nm (LDC 3100, Riviera Beach, FL) and a recording integrator. The analytical column was a 25 cm X 4.6 mm Spherisorb SS ODS2 column (Queensbury, U.K.) and the guard column was a RP-18 cartridge (Applied Biosystems, NJ). The mobile phase (pH 3.5) for the quantitation of lignocaine was 28:72 v/v acetonitrile/0.20J0 o-phosphoric acid containing 15 mmol triethylamine. The retention volumes for lignocaine and etidocaine (internal standard) were 7.6 and 18.5 ml, respectively. The mobile phase for the quantitation of bupivacaine was 35:65 acetonitrile/ 0.2OJo o-phosphoric acid containing 15 mmol triethylamine and the retention volumes for etidocaine (internal standard) and bupivacaine were 12.0 and 16.2 ml, respectively.
For the extraction of lignocaine, 160 p,l NaOH (IN), 520 p,l water and 100 p,l etidocaine solution (4 p,g/ml) were added to a 200 p,l plasma sample. For extraction of bupivacaine, 200 p,l NaOH (IN) and 100 p,l etidocaine solution (4 p,g/ml) were added to a 200 p,l plasma sample. The samples were then mixed, extracted with 4 ml of tert-butylmethylether and the organic phase separated by centrifugation. A 3.2 ml aliquot of the organic phase was then back-extracted with 150 p,l 0.005M o-phosphoric acid (O.01M for bupivacaine), and a 50 p,l aliquot of the aqueous phase was subjected to HPLC analysis. The assay was linear (r > 0.99) in the studied plasma concentration range (0.1-3.0 p,g/ml for lignocaine, 0.05-0.5 p,g/ml for bupivacaine) and the extraction efficiency (Mean ± SEM) of lignocaine and bupivacaine from spiked samples was 101.2 ± 1.8 (n=6) and 85.4 ± 3.5OJo (n=6) respectively.
Statistical analysis: A paired Student's t-test or the Mann-Whitney test, as appropriate, was used to evaluate differences between sets of data. Significance was assumed at the 5OJo level of confidence.
RESULTS
Effect of Dose Volume and Concentration: An increase in the administered dose volume of 2OJo lignocaine solution (0.1 to 0.25 mllkg) increased (I) the incidence of bilateral flaccid paresis to 100OJo at dose volumes of 0.2 mllkg or greater (Table 1) , and (2) the duration of sensory loss and loss of weight-bearing with a similar plateau effect at 0.15 to 0.2 mllkg. In terms of concentration effects, the 0.5OJo lignocaine solution produced no observable effect on any of the end points, and the 1.0OJo solution produced loss of sensation and weight-bearing in the absence of paresis ( Table 2 ). Bilateral flaccid paresis was only observed with the 2.0OJo lignocaine solution.
The time of onset for both loss of sensation and weight-bearing decreased with an increased volume of lignocaine, whereas volume effects were marginal on the time of onset for paresis (where it was observed). The time of onset for loss of sensation and weightbearing was also dependent on the administered agent, with the rank order effect being 2 OJo lignocaine < 2 OJo lignocaine with 1:200,000 adrenaline <0.5OJo bupivacaine (Table 3) , with significant differences between the lignocaine and bupivacaine solutions (P < 0.05). The time of onset of paresis was not statistically significant for the different agents (P> 0.05). Table 3 presents the effect of different agents on the duration of the three pharmacodynamic end points. At the administered dose volume of 0.2 mllkg, all agents produced the full range of responses and the rank order on duration was 0.5OJo bupivacaine > 2OJo lignocaine with 1 :200,000 adrenaline > 2 OJo lignocaine. In this model, the duration of paresis and loss of weightbearing after lignocaine-adrenaline was increased approximately 1.5 to 2-fold relative to plain lignocaine, whereas the duration of sensory loss was only marginally affected. The administration of bupivacaine increased the duration of all endpoints by a factor of approximately three-fold relative to administration of plain lignocaine solution.
Effect of Different Anaesthetic Agents:
Anunlhesw and flllen.\I\'e Care, Vol. 21, So. 3, June, 1993 Pharmacokinetic Profiles: The mean drug plasma concentration-time profiles after administration of either lignocaine (with or without adrenaline) or bupivacaine are presented in Figures 2 and 3 , respectively. The co-administration of adrenaline with lignocaine decreased the Cmax from 1.90±0.20 j.tg/ml to 1.67 ± 0.20 j.tg/ml (Mean ± SEM, n = 4, P> 0.05), 
DISCUSSION
The rabbit was chosen for the development of a noncatheterised animal model for studying epidural anaesthetics because of its convenient size, docile temperament and relatively low cost. These characteristics facilitated injection without the need for either sedation, which could interfere with subsequent endpoint assessment, or local anaesthesia, which could interfere with subsequent pharmacokinetic analysis. If required, these approaches may be used to facilitate operator experience and confidence in the performance of the block but are otherwise unnecessary. The epidural injections with relatively small needles caused no obvious discomfort to the animal which was only gently restrained.
The injection technique is relatively straightforward, with an overall success rate of greater than 85070. For an operator with previous experience in epidural techniques this level of expertise is readily attained. Failures include those abandoned where the loss-ofresistance or "pop" through the ligamentum flavum and a subsequent resistance-free injection could not be obtained, where blood (or rarely CSF) was present in the needle or where the animal moved during injection. In most small animals the spinal cord ends in the lower lumbar region with the meninges continuing to the middle of the sacrum. However, the dimensions of the sacral meningeal cul-de-sac are so small that needle penetration at the lumbosacral space is unlikely. 'i," Subarachnoid injection results in a characteristically sudden and profound onset of paresis and sensory loss. Inadvertent subarachnoid injection has occurred only twice in a total experience of over 400 injections. Misplacement of the injection into the region of the sciatic foramen results in a unilateral block with no associated analgesia of the tail. The small prospect of injection failure is offset against the absence of technique-related mortality or observed morbidity in any of the rabbits which have been studied. Each rabbit may be given multiple injections which, at intervals of one week, are well tolerated and show consistency of response.
The pharmacodynamic end points which have been chosen are crude by comparison with other more sophisticated animal models and obviously lack the subjective detail available from human studies. However, they offer the advantages of being simple, unambiguous and objective. Although experimental animals may rapidly become conditioned when testing for sensory analgesia, 15 this was not apparent using the modified tail-clamp procedure for assessing sensory blockade as placebo controls always responded appropriately. The loss of weight-bearing was moni-tored as an indicator of partially depressed motor activity, realising that proprioception and muscle spindle activity mediated by AI' fibres are also significant components in the maintenance of normal body posture in quadrupeds. The bilateral flaccid paresis endpoint was clearly indicative of complete motor blockade and was equivalent to a 8romage category 1 block. 16 The latency of onset in the rabbit was rapid for the three pharmacodynamic end points studied, and the order of effect was consistently sensory loss followed by the loss of weight-bearing ability and subsequent development of paresis (where it occurred). Furthermore, the latency of onset for sensory loss and the loss of weight-bearing were significantly longer for bupivacaine compared with lignocaine, which is broadly consistent with human clinical practice. I'" Although the rapidity of onset is not typical of human epidural blockade, it has been described in cats of comparable weight, and it was suggested that the rapidity of onset primarily reflected the period of time required for diffusion of drug from the epidural space through the small neural mass to the sites of action. 3 This may obscure differences in latency which might have otherwise been expected.
An increase in the administered mass of drug (volume and concentration effects described in Tables  1 and 2 ) resulted in an increase in the duration of the three measured pharmacodynamic end points and an increased intensity of blockade as indicated by the increased incidence of flaccid paresis. This is consistent with similar observations in other animal models 2,1 and in human clinical practice. 1-,," Similarly, the rank order duration of the three different local anaesthetic agents described in Table 3 on the duration of the pharmacodynamic end points in the rabbit model are broadly characteristic of their activity profiles in other animal models 2,1 and in clinical practice.I-,I< For example, bupivacaine had a significantly longer duration of action in all of the measured end points and the co-administration of adrenaline with lignocaine increased the duration of paresis and loss of weightbearing relative to a plain lignocaine solution. The lack of effect of adrenaline on the duration of lignocaineinduced sensory blockade is anomalous.
The pharmacokinetics of the different agents were determined to provide an insight into the rapidity of drug uptake from the epidural space of the rabbit and its subsequent disposition. Figures 2 and 3 indicate that both lignocaine and bupivacaine were rapidly absorbed. The addition of adrenaline to lignocaine significantly increased the T max value, while the decrease in the observed C max value was not statistically significant in this small study. The effect ·~nanlhe\·1(I and In{(!II';;'"(! Care, le)/. ]J, So. 3, june, /993 of co-administered adrenaline on the pharmacodynamic response was substantial ( Table 3) in terms of duration although the latency period was only marginally affected. On a separate occasion, the rapid absorption of bupivacaine was further studied by intravenously administering (in cross-over fashion via the marginal ear vein) the same dose of bupivacaine. In these studies, the plasma concentration-time profile of intravenous bupivacaine after the five-minute timepoint was very similar to that observed after epidural administration, indicating a rapid rate of absorption of bupivacaine from the epidural space (unpublished data).
In summary, the rabbit model which is described satisfies the requirements of simplicity, ease of use and interpretation of the end points, and has likely utility in screening of local anaesthetic agents intended for epidural use.
